Plants and human health in the twenty-first century

被引:515
作者
Raskin, I
Ribnicky, DM
Komarnytsky, S
Ilic, N
Poulev, A
Borisjuk, N
Brinker, A
Moreno, DA
Ripoll, C
Yakoby, N
O'Neal, JM
Cornwell, T
Pastor, I
Fridlender, B
机构
[1] Rutgers State Univ, Cook Coll, Biotech Ctr, New Brunswick, NJ 08901 USA
[2] Phytomed Inc, Dayton, NJ 08810 USA
关键词
D O I
10.1016/S0167-7799(02)02080-2
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The concept of growing crops for health rather than for food or fiber is slowly changing plant biotechnology and medicine. Rediscovery of the connection between plants and health is responsible for launching a new generation of botanical therapeutics that include plant-derived pharmaceuticals, multicomponent botanical drugs, dietary supplements, functional foods and plant-produced recombinant proteins, Many of these products will soon complement conventional pharmaceuticals in the treatment, prevention and diagnosis of diseases, while at the same time adding value to agriculture. Such complementation can be accelerated by developing better tools for the efficient exploration of diverse and mutually interacting arrays of phytochemicals and for the manipulation of the plant's ability to synthesize natural products and complex proteins. This review discusses the history, future, scientific background and regulatory issues related to botanical therapeutics.
引用
收藏
页码:522 / 531
页数:10
相关论文
共 78 条
[21]   The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava [J].
Ernst, E .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (01) :42-53
[22]   Alkaloid biosynthesis in plants: Biochemistry, cell biology, molecular regulation, and metabolic engineering applications [J].
Facchini, PJ .
ANNUAL REVIEW OF PLANT PHYSIOLOGY AND PLANT MOLECULAR BIOLOGY, 2001, 52 :29-66
[23]  
Farnsworth NormanR., 1988, Biodiversity, P83
[24]  
FARNSWORTH NR, 1976, AM J PHARM, V148, P46
[25]   Optimization of scFv antibody production in transgenic plants [J].
Fiedler, U ;
Phillips, J ;
Artsaenko, O ;
Conrad, U .
IMMUNOTECHNOLOGY, 1997, 3 (03) :205-216
[26]   SECRETION OF A FUNCTIONAL SINGLE-CHAIN FV PROTEIN IN TRANSGENIC TOBACCO PLANTS AND CELL-SUSPENSION CULTURES [J].
FIREK, S ;
DRAPER, J ;
OWEN, MRL ;
GANDECHA, A ;
COCKBURN, B ;
WHITELAM, GC .
PLANT MOLECULAR BIOLOGY, 1993, 23 (04) :861-870
[27]   Molecular farming of pharmaceutical proteins [J].
Fischer, R ;
Emans, N .
TRANSGENIC RESEARCH, 2000, 9 (4-5) :279-299
[28]   Metabolic engineering and applications of flavonoids [J].
Forkmann, G ;
Martens, S .
CURRENT OPINION IN BIOTECHNOLOGY, 2001, 12 (02) :155-160
[29]   Assembly, secretion, and vacuolar delivery of a hybrid immunoglobulin in plants [J].
Frigerio, L ;
Vine, ND ;
Pedrazzini, E ;
Hein, MB ;
Wang, F ;
Ma, JKC ;
Vitale, A .
PLANT PHYSIOLOGY, 2000, 123 (04) :1483-1493
[30]   Evaluation and use of plant biodiversity for food and pharmaceuticals [J].
Frusciante, L ;
Barone, A ;
Carputo, D ;
Ercolano, MR ;
della Rocca, F ;
Esposito, S .
FITOTERAPIA, 2000, 71 :S66-S72